Infliximab Infliximab (Remicade, Inflectra, Renflexis, infliximab-dyyb, and infliximab-abda) is a chimeric monoclonal antibody, used in the treatment of various autoimmune disorders like Crohn's disease, rheumatoid arthritis, ulcerative colitis, psoriasis, ankylosing spondylitis, psoriatic arthritis, and Behet's disease
But I suspect this approach doesnt work as well in biopharma: Getting permission to be contrarian in biopharma is difficult : if the goal is to prove a contrarian opinion around a drug market, the company needs to not only develop a drug with great clinical data, but also carry out a commercial launch
Because of this, its side effects are generally more pronounced and prolonged compared to standard IGF-1
explains why bruises can happen, who may be more likely to get them, and clear, practical steps to prevent and treat them so you can use semaglutide confidently without worrying about noticeable bruising, while feeling in control of your health and comfortable with the injection process